US Stocks
/
Aptevo Therapeutics Inc. Share Price

Aptevo Therapeutics Inc. Share Price

NASDAQ: APVO | Micro Cap
$1.80
-$0.02 (-1.37%) Last updated on 09 Oct, 2026 | 01:24 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Aptevo Therapeutics Inc. Stock Performance

Open
$1.80
Prev. Close
$1.82
Circuit Range
N/A
Day Range
$1.80 - $1.80
Year Range
$0.51 - $10.55
Volume
200
Average Traded
$1.80

Aptevo Therapeutics Inc. Share Price Today

As of 9 October 2026, Aptevo Therapeutics Inc.'s share price is $1.80. The stock opened at $1.80, compared to its previous close of $1.82. During today's trading session, Aptevo Therapeutics Inc.'s share price traded between $1.80 and $1.80, with an average price of $1.80. Over the past 52 weeks, the stock has recorded a high of $10.55 and a low of $0.51. In terms of performance, Aptevo Therapeutics Inc.'s share price has declined by 62.50% over the last six months and is up 16.88% on a year-on-year basis.

Aptevo Therapeutics Inc. Share Price Chart

$1.80$1.80
L
Show Current Price
H

Aptevo Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$567963.00
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-15.46
Revenue (TTM)
$0.00
Return On Equity (TTM)
-463.15%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
29.57%

Aptevo Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$9.03-$5.90-$6.70-$6.36
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A34.66%-13.56%5.07%

Aptevo Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$3.11$0.00$0.00$0.00
Net Profit$8.03-$17.41-$24.13-$27.54
Net Profit Margin258.20%N/AN/AN/A
Income ChangeN/A-316.81%-38.60%-14.13%

About Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, CD3xCD123, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Aptevo Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.80
$1.80
-2.70%
Sep 2026
$2.42
$1.85
-21.28%
Aug 2026
$3.92
$2.35
-43.31%
Jul 2026
$4.33
$4.14
-5.26%
Jun 2026
$5.00
$4.38
-10.90%
May 2026
$4.65
$4.91
+2.29%
Apr 2026
$4.11
$4.80
+13.21%
Mar 2026
$6.81
$4.24
-41.92%
Feb 2026
$7.63
$7.30
+0.69%
Jan 2026
$9.35
$7.25
-22.29%
Dec 2025
$1.37
$9.33
+578.55%
Nov 2025
$1.51
$1.38
-10.71%

APVO Share Price FAQs

What is Aptevo Therapeutics Inc. share price today?

chevron-up
Aptevo Therapeutics Inc. share price today is $1.80 as on October 9, 2026 at 1:24 am IST.

What is the 52 week high and 52 week low of Aptevo Therapeutics Inc. stock?

chevron-up
The 52 week high of Aptevo Therapeutics Inc. stock is $10.55, while the 52 week low is $0.51 as of 9 Oct '26.

What is APVO's market capitalisation today?

chevron-up
APVO market capitalisation is $567963.00 as of October 9, 2026, at 6:11 pm IST.

What is APVO's net income for the last quarter?

chevron-up
APVO's net income for the last quarter is -6.36B USD.

What is the 5 year returns of APVO?

chevron-up
The 5 year returns of APVO is -100.00% as on 9 Oct '26.

What is the high & low stock price of APVO today?

chevron-up
APVO stock price hit a high of $1.80 and low of $1.80 as of 9 Oct '26.

Can I buy APVO shares in India?

chevron-up
Yes. You can buy APVO in India by opening an international trading account.